A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.
about
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimodWhat do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugsBiosimilar insulins: a European perspectiveDrugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysisChanging the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EUOpen Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical BioequivalenceEfficiency of Original versus Generic Intravenous Iron Formulations in Patients on HaemodialysisGeneric medicines: an evaluation of the accuracy and accessibility of information available on the InternetA method for the design and development of medical or health care information websites to optimize search engine results page rankings on GoogleCombinatorial screening for specific drug solubilizers with switchable release profiles.Efficacy and Safety of Dorocontin(®) versus Sustac(®) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial.Generic medicines and generic substitution: contrasting perspectives of stakeholders in IrelandGeneralizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds.Pharmacy switch of antipsychotic medications: patient's perspective.FDA Policy and Cardiovascular Medicine.Perceptions of generic medication in the general population, doctors and pharmacists: a systematic reviewAdherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claimsA cross-sectional survey of pharmacists to understand their personal preference of brand and generic over-the-counter medications used to treat common health conditions.Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.Barriers to the uptake of biosimilars and possible solutions: a Belgian case study.Generic medicines: issues and relevance for global health.What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers' and Patients' Perceptions of, and Experiences with, Generic Medicines.Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial.Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults.Beliefs, perceptions and behaviours of GPs towards generic medicines.The diffusion of generics after patent expiry in Germany.Impact of generic substitution practice on care of diabetic patients.Orphan diseases: state of the drug discovery art.Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.Categorization and association analysis of risk factors for adverse drug events.Development of one paediatric and one neonatal formulary list in hospital settings.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.Iron sucrose: assessing the similarity between the originator drug and its intended copies.Patient perceptions of generic medicines: a mixed-methods study.Pharmacological and non-pharmacological treatment preferences of healthcare professionals and proxies for challenging behaviors in patients with dementia.The use of generics to treat chronic hepatitis C: not quite ready for the big stage.
P2860
Q26740235-174649FE-4F88-4C7A-8E39-770611C8A8C4Q26801726-0AA7AE68-1FA2-49D2-9F11-4612C95F2FA7Q27026596-CFB17B95-4CD9-4904-AC3A-DF13C4858B0CQ27316535-6BF2FA72-3D61-40F0-9CEC-86B064359F0BQ28086893-2FA406A4-0DA0-4C8E-9F6F-0B07C1D99611Q28468358-62C266EE-A585-43C8-B7DC-30E4E5CC3699Q28547636-6C4323F1-2941-48D3-925A-319A881A206CQ28661314-BA2910DF-6C35-4279-BA1C-F6B1FB53B8C2Q28681341-7F12EB97-4472-41B8-A35C-9EE82E21D3C1Q35537690-131825E2-6A58-4CE5-A837-1E04395E3520Q35763860-C35A1C30-CF04-485A-9F8D-1D683AED834CQ35869235-A6C3C2A1-4E7A-4883-A5C2-C9493FDCF72CQ36047276-00685548-4969-4D9A-BFFB-0310E14FD174Q36093400-767FF15A-0042-4343-AFEF-ACC976092F76Q36100416-F432E796-497A-4EDA-B169-FBF52D858DEBQ36374308-026429F4-0B0F-45F5-A057-9113F47918DFQ36507828-0317BD04-38D2-4191-8D2B-C1A3FC05B9D6Q36820439-4B9BEC11-057E-4105-9789-0D0097947EB5Q37103050-E8A1E944-27B3-47EB-9BA3-C79DA6906BCCQ38209872-C5ADFAB4-DDFE-4368-B4A4-8A0730710E43Q38592725-CD6CBCC0-B0CF-4084-896A-A21AB3F01F6FQ38824629-C3027DE5-06E1-45B7-AE5B-1E1155E03973Q39021246-720DF177-DA23-4059-88C8-405C260A4701Q39200785-99BBB369-8593-4690-95F0-2CF4ADB53456Q40197904-7EA09096-589C-45A1-8A59-23452C9CA8C2Q40316218-6EB4D753-2A37-4D3F-9DD6-119FA23AD029Q43855810-DC622BE0-A81A-433E-A7C0-B8E9747A35C2Q45882722-EF0FEF51-DDD4-42C0-B75D-F1265CF9898DQ47114415-B658D4E2-D5D3-4C65-9D53-933AA8F7104AQ47339342-0645710B-29EF-43D0-BAF2-32B18A12C2C1Q47894351-2FD29EC1-CF81-4DF5-AC47-804ACA2C38AAQ47998668-19FDC76C-7677-4F31-8185-0F13D8A3C8EFQ49720109-6D8C9DB1-5670-44DF-B9E7-EA7E0AAD4A8DQ50737387-8A8CA2F4-34EB-4E00-AA2F-FFB014E4E3C9Q53626464-F86F7935-B2D4-411C-9217-064375D71368Q54574742-827E7EC2-B812-49BF-B68D-80F1A6D39614
P2860
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A review of the differences an ...... using Ireland as a case study.
@ast
A review of the differences an ...... using Ireland as a case study.
@en
A review of the differences an ...... using Ireland as a case study.
@nl
type
label
A review of the differences an ...... using Ireland as a case study.
@ast
A review of the differences an ...... using Ireland as a case study.
@en
A review of the differences an ...... using Ireland as a case study.
@nl
prefLabel
A review of the differences an ...... using Ireland as a case study.
@ast
A review of the differences an ...... using Ireland as a case study.
@en
A review of the differences an ...... using Ireland as a case study.
@nl
P2093
P2860
P356
P1476
A review of the differences an ...... using Ireland as a case study
@en
P2093
Bill Shannon
Colum Dunne
Suzanne Dunne
P2860
P2888
P356
10.1186/2050-6511-14-1
P577
2013-01-05T00:00:00Z
P5875
P6179
1024059082